Atorvastatin vs Rosuvastatin: Nutrient Depletion Comparison
Compare YOUR medications' depletionsFree, 10 seconds →
At a Glance
Atorvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway that produces both cholesterol and CoQ10. By blocking this shared pathway, atorvastatin reduces CoQ10 synthesis by 40% within the first 30 days of treatment — the same molecular bottleneck that makes statins effective for cholesterol also starves mitochondria of their primary electron carrier. CTD documents 340 gene interactions for atorvastatin, including effects on vitamin D hydroxylation enzymes and vitamin K-dependent carboxylation proteins that activate osteocalcin for bone mineralization.
Atorvastatin has only 14% oral bioavailability due to extensive first-pass CYP3A4 metabolism, but its active metabolites extend the effective half-life to 20–30 hours, providing sustained HMG-CoA reductase inhibition despite the parent drug's 14-hour half-life.
- ✓Most extensively studied statin: ChEMBL documents 368 RCTs across 850,148 patients
- ✓Long effective half-life allows flexible dosing — morning or evening administration equally effective
- ✓Generic availability since 2011 keeps costs low for long-term treatment plus supplementation
- ✓Proven cardiovascular outcomes in landmark trials (ASCOT-LLA, TNT, SPARCL) across primary and secondary prevention
- ✗CYP3A4-dependent metabolism creates significant drug interaction risks with macrolides, azole antifungals, and grapefruit
- ✗FAERS logs 172,934 adverse event reports with a 10.8% death-associated rate
- ✗340 CTD gene interactions suggest broader off-target metabolic effects beyond cholesterol lowering
- ✗Higher reported rates of muscle complaints — the most common reason patients discontinue statin therapy
Patients with established cardiovascular disease needing high-intensity lipid lowering who are not on CYP3A4-interacting medications and can commit to CoQ10 supplementation.
Rosuvastatin inhibits HMG-CoA reductase through the same mevalonate pathway blockade, depleting CoQ10 at comparable rates. However, rosuvastatin is more hydrophilic than atorvastatin, which limits its penetration into non-hepatic tissues — potentially reducing muscle-related CoQ10 depletion while maintaining equivalent hepatic cholesterol reduction. CTD identifies only 40 gene interactions for rosuvastatin, a dramatically narrower footprint that may reflect more selective hepatic targeting with fewer systemic off-target effects.
Rosuvastatin achieves 20% oral bioavailability (higher than atorvastatin's 14%) with a 19-hour half-life and minimal CYP metabolism — primarily cleared through hepatic uptake via OATP1B1 transporters and biliary excretion.
- ✓Most potent statin per milligram — 5 mg rosuvastatin matches approximately 10 mg atorvastatin for LDL reduction
- ✓Minimal CYP450 metabolism means far fewer drug-drug interactions than atorvastatin
- ✓Narrower gene interaction profile (40 vs 340 in CTD) suggests more selective action
- ✓According to FAERS analysis of 112,860 reports, the death-associated rate is lower (4.5% vs atorvastatin's 10.8%)
- ✗FAERS still logs 112,860 adverse event reports — substantial even if fewer than atorvastatin
- ✗Higher cost than generic atorvastatin, which adds up for lifelong therapy plus supplements
- ✗Less long-term outcomes data compared to atorvastatin's decades of landmark trials
- ✗OATP1B1 transporter variants (PharmGKB Level 1A evidence) can dramatically alter blood levels in some patients
Patients taking multiple medications who need to minimize drug interactions, or those who experienced muscle pain on atorvastatin and want a more hydrophilic alternative.
Feature Comparison
| Feature | Atorvastatin | Rosuvastatin |
|---|---|---|
| Drug Class | HMG-CoA reductase inhibitor (lipophilic) | HMG-CoA reductase inhibitor (hydrophilic) |
| Nutrients Depleted | 3 — CoQ10, vitamin D, vitamin K2 | 3 — CoQ10, vitamin D, vitamin K2 |
| CTD Gene Interactions | 340 documented | 40 documented |
| Bioavailability | 14% | 20% |
| Half-Life | 14 hours (active metabolites 20–30 h) | 19 hours |
| Primary Metabolism | CYP3A4 (hepatic oxidation) | Minimal CYP; OATP1B1 hepatic uptake |
| FAERS Reports | 172,934 (10.8% death-associated) | 112,860 (4.5% death-associated) |
| LDL Potency (per mg) | Moderate — 80 mg max dose | High — 40 mg max dose |
Wondering which medication depletes less?
Check your medications free — 10 seconds →Verdict
Both statins deplete identical nutrients through the same mevalonate pathway blockade — your CoQ10, vitamin D, and K2 supplementation protocol stays the same regardless of which you take. The real differentiator is pharmacology. Atorvastatin brings unmatched clinical evidence (368 RCTs, 850,148 patients in ChEMBL) but its CYP3A4 metabolism creates drug interaction headaches and its 340 CTD gene interactions suggest broader systemic effects. Rosuvastatin offers greater potency per milligram, a cleaner interaction profile, and a significantly lower FAERS death-associated rate (4.5% vs 10.8%). For patients already on complex medication regimens, rosuvastatin's minimal CYP involvement is a genuine safety advantage. For cost-sensitive patients with simple medication profiles, generic atorvastatin delivers proven outcomes at a fraction of the price.
FAQ
References
- [1]CTD (Comparative Toxicogenomics Database): 340 gene interactions for atorvastatin, 5,392 disease associations; 40 gene interactions for rosuvastatin, 1,740 disease associations
- [2]ChEMBL bioactivity database: 368 randomized controlled trials for atorvastatin across 850,148 enrolled patients
- [3]FAERS (FDA Adverse Event Reporting System): 172,934 atorvastatin reports (10.8% death-associated), 112,860 rosuvastatin reports (4.5% death-associated)
- [4]PharmGKB pharmacogenomics database: SLCO1B1 Level 1A evidence for statin-induced myopathy risk with both atorvastatin and rosuvastatin
- [5]PubMed PMID 27838722 — Naci H et al. Comparative tolerability and harms of individual statins. Circulation: Cardiovascular Quality and Outcomes. 2013;6(4):390-399
Check your medications
Check Free →